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Mast cells of connective tissue contain in their
cytoplasmic granules acid mucopolysaccharides
of the hyaluronic acid and heparin type, hista-
mine, and, at least in certain species, serotonin.
Hyaluronie acid is a ground substance mucopoly-
saccharide with strong water-binding capacity.
In fresh edemas of the corium, as e.g. in urti-
canal wheals of short-timed standing, the mast
cells are degranulated and hardly identifiable.
In chronic edemas, as e.g. edemas of the legs
due to venous stasis, the number of mast cells is
significantly increased, the extracellular sub-
stance is ample and stains metachromatically
by toluidine blue, indicating acid mucopolysac-
charide; it is partly sensitive to influence of
bacterial hyaluronidase and contains considerable
amounts of hyaluronic acid.
In myxedema, the mast cells of skin connective
tissue are numerous, in various granulation
phases; and the ground substance contains ample
amounts of hyaluronate as well as chondroitin
sulfate.
Localized, pretibial myxedema occurs in pa-
tients with thyrotrophic hyperactivity, especially
in cases where the inhibitory influence of the
thyroid gland is suddenly removed (e.g. by
thyroidectomy or treatment with radioactive
iodine). The skin connective tissue occupies a
very thick layer. The fibres are split apart by
mucinous ground substance. The subcutaneous
fat is sparse and partially replaced by a mucinous
substance characterized by a large content of
hyaluronate and chondroitin sulfate. An out-
standing feature in the myxedematous connective
tissue is the accumulation of mast cells.
The influence of tissue water on connective
tissue regeneration has been studied in experi-
mental edemas. Injection of physiological saline
or Tyrode's fluid into skin connective tissue
brings about a degranulation of the mast cells
within minutes. This has been observed in
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human skin as well as in skin of experimental
animals.
Cheek pouches of living hamsters have been
used for studies of edema. If physiological saline
or Tyrode's solution was injected between the
membranes of a cheek pouch or dropped on the
connective tissue surface of a surgically split
pouch, the mast cells degranulated, i.e. lost their
granules, and a cytoplasmic structure resembling
a honey-comb or a sponge became visible in
stained or unstained cells. Around the cells was a
zone of an unstructured material, which gave a
more or less intense metachromatic stain with
toluidine blue. This staining was prevented, if the
tissue was pre-treated for ten minutes with testic-
ular or bacterial hyaluronidase. The degranulated
cells were able to regranulate. Water, on the other
hand, brought about an irreversible disintegra-
tion of the cells, due to osmotic forces. Physical
traumatization brought about an edema and a
traumatization brings about an edema and a
degranulation as well as a disruption of the mast
cells.
Shock, systemically administered histamine,
histamine-liberator substances, and serotonin
produced edema and mast-cell degranulation.
In another series of experiments the basis of
one of the two cheek pouches was ligated with a
silk suture, and venous stasis produced. After 24
hours the pouch appeared as a grape-like sac
filled with a mucinous, gelatinous edema fluid.
If cut up, the material did not flow out. Contact
with hyaluronidase of testicular or bacterial
origin changed the viscous material into a watery
fluid. The fluid took a metachromatic stain with
toluidine blue, indicating a content of highly
polymerized acid mucopolysaccharide. By paper
chromatography it was shown, that 24 hours after
the ligation, the edema fluid contained consider-
able amounts of glucosamine, but practically no
galactosamine. After 48 hours it contained 80%
glueosamine and about 20% galactosamine.
35S-labeled sodium sulfate was injected intra-
peritoneally in doses of 4 C per gram body
weight. The content of 35S in the tissue and in
the edema fluid was determined by the method of
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Kodicek and Loewi (1955), modified by Moltke
(1957). 24 hours after the ligation the amount
of 35S in the tissue was found to be 55% higher
than that of blood plasma whereas the content
of the edema fluid was 36% lower than the con-
tent in plasma.
The first day there was an abrupt decrease in
the number of identifiable mast cells. From the 2.
to the 7. day the number and granularity of the
mast cells were increasing along with an
increasing content of sulfomucopolysaccharide
measured as 35S-sulfate.
CONCLUSIONS
Increased tissue water is a physiological stimu-
lus bringing about a granule release from the mast
cells to the extracellular compartment. The mate-
rial, which is unstructured after leaving the cell,
contains hyaluronic acid, a water-binding acid
mucopolysaccharide. A mucinous organization of
the water takes place, a conversion of the water
into a mucinous gel or sort of connective-tissue
ground-substance. In experiments on hamsters
and other animals it has been shown that thyro-
trophic anterior pituitary hormone stimulates
the mucinous system of connective tissue, an
effect contrasting to the inhibitory effect of
cortisone. The mast cells are numerous, large and
filled with metachromatic material.
If venous stasis is produced in individuals
influenced by thyrotrophin hyperactivity, e.g.
individuals treated with thyroidectomy or with
thyroidectomy plus thyrotrophin injections, there
will be an increase in tissue water or an edema.
In this case, however, the intracellular muco-
polysaccharide material available is much more
ample. When the substance is released to the
extracellular compartment, we find the picture of
a strongly mucinous edema, of a myxedema. The
thyrotrophin influence on connective tissue may
determine the difference between an edema due
to venous stasis and a localized myxedema.
Hypothyroid myxedema may be due to a simi-
lar mechanism, a capillary damage being the
primary cause of an increase in tissue water.
Myxedematous organisms are in lack of thyroid
hormone, which normally balances the thyro-
trophin release from the pituitary.
If in endocrinologically normal and well-
balanced individuals a mucopolysaccharide con-
taining edema persists, a fiber deposition will take
place, a fibrous organization, which is well known
in chronic stasis edemas. In myxedematous
subjects this process seems to be inhibited for
some reason, and the thyrotrophin effect on
connective tissue is different from that of soma-
totrophin which stimulates the formation of
collagen fibres.
DISCUSSION
DR. EDMUND KLEIN (Boston Mass.): I would
like to ask whether you found any differences in
the behavior of the perivascular mast cells in the
cheek pouches compared to the ones more distant?
DR. WALTER C. Lonrpz, JR. (Hanover, N.H.):
Are these tissue cells of the hamsters the same
chemically and histochemically as the cells of the
human?
DR. FREDERICK D. MALKINSON, (Chicago,
Ill.): I enjoyed Dr. Asboe-Hansen's paper very
much. He offers for pretibial myxedema an
intriguing explanation for a problem that is
always a puzzle to dermatologists regarding a
number of cutaneous disorders, namely, specific
localization of lesions. There is considerable
doubt in my mind, however, as to whether we
should continue to regard elevated levels of thy-
roid stimulating hormone (TSH) as the etiologic
factor in pretibial myxedema. Histologically
localized and generalized myxederna are essen-
tially indistinguishable. Recently Gabrilove and
Ludwig have shown that the microscopic skin
changes are identical in primary and in secondary
generalized myxedema (the latter condition fol-
lowing lowered levels of TSII as seen, for example,
in Sheehan's syndrome of infarction of the ante-
rior pituitary after prolonged post-partum hem-
orrhage). Furthermore the cutaneous changes in
secondary myxedema are reversible by the ad-
ministration of TSH. It is true that the clinical
response of pretibial myxedema to desiccated thy-
roid in unpredictable, but it is known that certain
cases of generalized myxedema (juvenile myx-
edema) also fail to respond to desiccated thyroid.
Such cases will respond to triiodothyronine, how-
ever, and it has also been recently shown that
regression of the lesions of pretibial myxedema
may occur following local injections of triiodothy-
ronine.
In the light of these more recent studies it
would seem more plausible to assume that the
pathogenesis of pretibial myxedema does not lie
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in an elevation of TSH serum levels but in one
of two other possibilities: that there is either an
inadequate vascular supply to the affected areas
resulting in a local deficiency of triiodothyronine
or other thyroid hormonal substances, or, more
likely, that there is a localized defect in the ability
of the skin to convert thyroid hormones meta-
bolically into their tissue-active forms.
Da. STEPHEN ROTHMAN (Chicago, Ill.): Can
the hyaluronic acid be identified in the tissue
fluids of urticarial wheals?
Da. GUSTAV ASBOE-HANSEN (in closing): In
answer to Dr. Klein as to whether there is a
difference between the reactions of the peri-
vascular mast cells and the others: I think there
is a time difference. The perivaseular mast cells
regranulate to a much higher extent and much
more quickly than the cells free in the connective
tissue. We have observed this in various condi-
tions.
In answer to Dr. Lobitz concerning the hamster
cells and human mast cells: There are certainly
differences between the species, for example, as
to the serotonin content. I am not able to answer
the question what cytochemical differences there
are between hamster mast cells and human cells.
I only know their contents seem to be very simi-
lar.
To Dr. Malkinson: I would not maintain that
all these problems are clarified; there are certain
of them—very essential ones—we do not know
about in myxedema and the treatment especially.
I would not take Dr. Ludwig's work into this
discussion, because first, he has only six cases,
and secondly, it is very difficult indeed to diagnose
secondary myxedema. In animal experiments
there is sufficient chemical and morphological
evidence to differentiate between secondary and
primary myxedema. We have been studying the
dwarf mouse thoroughly. It is an outstanding
member of the animal world characterized by an
agenesis of the anterior pituitary gland. It has
secondary myxedema. Studies of the skin of these
dwarf mice, untreated as well as under thyro-
trophin influence, have confirmed that thyro-
trophin stimulates the production of ground-
substance mucopolysaccharides in the connective
tissue.
In answer to Dr. Rothman: I do not think it is
possible to determine variations in the hyaluronic
acid of urticarial wheals. The amount would be
very, very small. It is impossible also to evaluate
the amount histochemically. I would not rely on
that.
